Clinical Trials on Hormone Refractory
Total 37118 results
-
Veeda OncologyBayerTerminatedHormone Refractory Prostate CancerUnited States
-
Zhengzhou UniversityThe First Affiliated Hospital of Zhengzhou University; Xinyang Central Hospital and other collaboratorsUnknown
-
CytoVac A/SCompletedHormone-refractory Prostate CancerDenmark
-
University of FloridaCureVacTerminated
-
National University Hospital, SingaporeCompletedHormone-Refractory Prostate CancerSingapore
-
CytRxCompletedHormone Refractory Prostate CancerUnited States
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States, Russian Federation
-
Merrion Pharmaceuticals, LLCCompletedHormone-Refractory Prostate CancerUnited States, Estonia, Latvia
-
David M LubaroffUnited States Department of DefenseCompletedHormone Refractory Prostate CancerUnited States
-
Duke UniversityUnited States Department of DefenseCompletedMetastatic Hormone Refractory Prostate CancerUnited States
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate CancerUnited States
-
CelgeneCompletedHormone Refractory Prostate CancerUnited States
-
Queen's Medical CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHormone Refractory Prostate CancerUnited States
-
Spanish Oncology Genito-Urinary GroupCompleted
-
Assistance Publique Hopitaux De MarseilleUnknownAny Cancer With Multiple Bone MetastasesFrance
-
Duke UniversityBristol-Myers SquibbTerminatedPancreatic Adenocarcinoma | Refractory Solid TumorsUnited States
-
Daniel George, MDNovartis PharmaceuticalsCompletedHormone Refractory Prostate CancerUnited States
-
DendreonCompletedHormone-Refractory Prostate Cancer
-
Medical University of ViennaUnknownHormone Refractory Prostate CancerAustria
-
Sheba Medical CenterUnknownHormone Refractory Prostate CancerIsrael
-
National Health Research Institutes, TaiwanNational Cheng-Kung University HospitalRecruiting
-
Second Affiliated Hospital of Soochow UniversityRecruitingAdvanced Refractory Solid TumorsChina
-
CStone PharmaceuticalsBayerCompletedAdvanced Refractory Solid TumorsAustralia
-
Eli Lilly and CompanyCompletedCancer | Refractory Solid TumorUnited States
-
SCRI Development Innovations, LLCNovartisCompletedAdvanced Malignancies | Refractory MalignancyUnited States
-
Nerviano Medical SciencesCompletedMetastatic Hormone Refractory Prostate CancerItaly
-
Madeline FieldsRecruitingDrug Resistant Epilepsy | Refractory Epilepsy | Medically Refractory EpilepsyUnited States
-
Ruijin HospitalUTC Therapeutics Inc.RecruitingRefractory Malignant Solid NeoplasmChina
-
Ruijin HospitalRecruitingRefractory Solid TumorsChina
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
SupremeCure Pharma Inc.WithdrawnRefractory Solid Tumor
-
SCRI Development Innovations, LLCBayerCompletedRefractory Solid TumorsUnited States
-
Vertex Pharmaceuticals IncorporatedNational Cancer Institute (NCI)WithdrawnRefractory Solid TumorsUnited States
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Previously Treated Myelodysplastic Syndromes | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess Blasts in TransformationUnited States
-
National Cancer Institute (NCI)CompletedRefractory Differentiated Thyroid Gland Carcinoma | Unresectable Thyroid Gland Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Refractory Thyroid Gland Hurthle Cell CarcinomaUnited States, Canada
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Technische Universität DresdenAbbVieActive, not recruitingRelapsed Adult AML | Refractory AMLGermany
-
Taivex Therapeutics CorporationActive, not recruitingAdvanced Refractory Solid TumorsTaiwan
-
Taivex Therapeutics CorporationCompletedAdvanced Refractory Solid TumorsTaiwan
-
Sunshine Lake Pharma Co., Ltd.CompletedAdvanced Refractory Solid TumorsChina
-
Nantes University HospitalWithdrawnCD22+ Relapsed/Refractory B-ALLFrance
-
National OncoVentureChong Kun Dang PharmaceuticalUnknownAdvanced Refractory Solid TumorsKorea, Republic of
-
Piramal Enterprises LimitedSuspendedAdvanced Refractory Solid TumorsUnited States, India
-
Piramal Enterprises LimitedSuspendedAdvanced Refractory Solid TumorsUnited States, India
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedMalignant Tumors | Refractory TumorsFrance
-
Stanford UniversityAmgen; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedRefractory Leukemia | Refractory Solid Tumors | Relapsed Solid Tumors | Relapsed LeukemiaUnited States, Canada
-
Centre Hospitalier Universitaire de NiceUnknown
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate Cancer DiseaseUnited States